BRIEF-Cynata Therapeutics says FDA Grants orphan drug designation to cymerus msc product, cyp-001
March 28, 2018 at 08:17 AM EDT
* FDA GRANTS ORPHAN DRUG DESIGNATION TO CYNATA’S LEAD CYMERUS™ MSC PRODUCT, CYP-001
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|